000			02188 a2200601 4500
005			20250517052403.0
264		0	_c20160209
008			201602s 0 0 eng d
022			_a1538-7445
024	7		_a10.1158/0008-5472.CAN-15-0509 _2doi
040			_aNLM _beng _cNLM
100	1		_aSingleton, Katherine R
245	0	0	_aKinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC. _h[electronic resource]
260			_bCancer research _cOct 2015
300			_a4398-406 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBenzamides _xpharmacology
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDrug Synergism
650	0	4	_aGene Library
650	0	4	_aGenes, Essential
650	0	4	_aGenomics _xmethods
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMorpholines _xpharmacology
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aProtein Binding
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aPyrazoles _xpharmacology
650	0	4	_aPyrimidines
650	0	4	_aRNA Interference
650	0	4	_aRNA, Small Interfering _xgenetics
650	0	4	_aReceptor, Fibroblast Growth Factor, Type 1 _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aHinz, Trista K
700	1		_aKleczko, Emily K
700	1		_aMarek, Lindsay A
700	1		_aKwak, Jeff
700	1		_aHarp, Taylor
700	1		_aKim, Jihye
700	1		_aTan, Aik Choon
700	1		_aHeasley, Lynn E
773	0		_tCancer research _gvol. 75 _gno. 20 _gp. 4398-406
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-15-0509 _zAvailable from publisher's website
999			_c25251025 _d25251025